These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 8924195)

  • 1. Predicting duration of clinical stability following haloperidol withdrawal in schizophrenic patients.
    van Kammen DP; Kelley ME; Gurklis JA; Gilbertson MW; Yao JK; Condray R; Peters JL
    Neuropsychopharmacology; 1996 Apr; 14(4):275-83. PubMed ID: 8924195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CSF norepinephrine in schizophrenia is elevated prior to relapse after haloperidol withdrawal.
    van Kammen DP; Peters J; van Kammen WB; Nugent A; Goetz KL; Yao J; Linnoila M
    Biol Psychiatry; 1989 Jun; 26(2):176-88. PubMed ID: 2472177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noradrenergic activity and prediction of psychotic relapse following haloperidol withdrawal in schizophrenia.
    van Kammen DP; Agren H; Yao JK; O'Connor DT; Gurklis J; Peters JL
    Am J Psychiatry; 1994 Mar; 151(3):379-84. PubMed ID: 7509126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral vs biochemical prediction of clinical stability following haloperidol withdrawal in schizophrenia.
    van Kammen DP; Kelley ME; Gurklis JA; Gilbertson MW; Yao JK; Peters JL
    Arch Gen Psychiatry; 1995 Aug; 52(8):673-8. PubMed ID: 7543265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine turnover in schizophrenia before and after haloperidol withdrawal. CSF, plasma, and urine studies.
    Beuger M; van Kammen DP; Kelley ME; Yao J
    Neuropsychopharmacology; 1996 Jul; 15(1):75-86. PubMed ID: 8797194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increases in CSF levels of interleukin-2 in schizophrenia: effects of recurrence of psychosis and medication status.
    McAllister CG; van Kammen DP; Rehn TJ; Miller AL; Gurklis J; Kelley ME; Yao J; Peters JL
    Am J Psychiatry; 1995 Sep; 152(9):1291-7. PubMed ID: 7653683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid corticotropin-releasing factor increases following haloperidol withdrawal in chronic schizophrenia.
    Forman SD; Bissette G; Yao J; Nemeroff CB; van Kammen DP
    Schizophr Res; 1994 Apr; 12(1):43-51. PubMed ID: 8018584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Norepinephrine in acute exacerbations of chronic schizophrenia. Negative symptoms revisited.
    van Kammen DP; Peters J; Yao J; van Kammen WB; Neylan T; Shaw D; Linnoila M
    Arch Gen Psychiatry; 1990 Feb; 47(2):161-8. PubMed ID: 1689140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting haloperidol treatment response in chronic schizophrenia.
    van Kammen DP; Kelley ME; Yao JK; Gilbertson MW; Gurklis JA; Inosaka T; Saito H; Peters JL; Sato M
    Psychiatry Res; 1996 Aug; 64(1):47-58. PubMed ID: 8888364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Erythrocyte ketone reductase activity, total plasma haloperidol and acute psychoses].
    Dutoit D; Thomas P; Leroux JM; Vaiga G; Pommery J; Cottencin O; Erb F; Goudemand M
    Encephale; 1995; 21(6):417-24. PubMed ID: 8674466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of catecholamine metabolism in schizophrenia/psychosis--II.
    Maas JW; Contreras SA; Miller AL; Berman N; Bowden CL; Javors MA; Seleshi E; Weintraub SE
    Neuropsychopharmacology; 1993 Feb; 8(2):111-6. PubMed ID: 8471122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quetiapine and norquetiapine in plasma and cerebrospinal fluid of schizophrenic patients treated with quetiapine: correlations to clinical outcome and HVA, 5-HIAA, and MHPG in CSF.
    Nikisch G; Baumann P; Wiedemann G; Kiessling B; Weisser H; Hertel A; Yoshitake T; Kehr J; Mathé AA
    J Clin Psychopharmacol; 2010 Oct; 30(5):496-503. PubMed ID: 20814316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. First-episode neuroleptic-free schizophrenics: concentrations of monoamines and their metabolites in plasma and their correlations with clinical responses to haloperidol treatment.
    Nagaoka S; Iwamoto N; Arai H
    Biol Psychiatry; 1997 Apr; 41(8):857-64. PubMed ID: 9099412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pupillary constriction during haloperidol treatment as a predictor of relapse following drug withdrawal in schizophrenic patients.
    Steinhauer SR; van Kammen DP; Colbert K; Peters JL; Zubin J
    Psychiatry Res; 1992 Sep; 43(3):287-98. PubMed ID: 1438625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma catecholamine metabolites as markers for psychosis and antipsychotic response in schizophrenia.
    Kelley ME; Yao JK; van Kammen DP
    Neuropsychopharmacology; 1999 Jun; 20(6):603-11. PubMed ID: 10327429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma catecholamine metabolites and early response to haloperidol.
    Bowers MB; Swigar ME; Jatlow PI; Goicoechea N
    J Clin Psychiatry; 1984 Jun; 45(6):248-51. PubMed ID: 6725216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of withdrawal of typical and atypical antipsychotic drugs: a case study.
    Alphs LD; Lee HS
    J Clin Psychiatry; 1991 Aug; 52(8):346-8. PubMed ID: 1869497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of risperidone and haloperidol for the prevention of relapse in patients with schizophrenia.
    Csernansky JG; Mahmoud R; Brenner R;
    N Engl J Med; 2002 Jan; 346(1):16-22. PubMed ID: 11777998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.